🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, double-blind, placebo-controlled, single ascending dose (SAD)...
Status
Completed
Location
Nucleus Network
Start Date
2024-07-10
Trial ID
NCT06535841
Symptoms of generalized anxiety is common in the general population and is ...
Status
Recruiting
Location
Region Kronoberg
Start Date
2020-10-19
Trial ID
NCT04702711
Treatments Being Tested
Preclinical data support the hypothesis that the administration of AHRO-001...
Status
Unknown
Location
City Hospital #15
Start Date
2013-06
Trial ID
NCT01931241
Treatments Being Tested
This study will evaluate the effectiveness of a school-based social cogniti...
Status
Completed
Location
The Children's Hospital of Philadelphia
Start Date
2007-10
Trial ID
NCT00510094
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics (PK), a...
Status
Completed
Location
Research Site
Start Date
2023-11-07
Trial ID
NCT06122714
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Simbec-Orion Clinical Pharmacology
Start Date
2021-05-13
Trial ID
NCT04931147
Treatments Being Tested
This study investigates the effectiveness of a short self-compassion mental...
Status
Completed
Location
Muhammad Rizwan
Start Date
2024-02-10
Trial ID
NCT06544044
Treatments Being Tested
The goal of this First-In-Human (FIH) trial is to learn about safety, toler...
Status
Not Yet Recruiting
Location
Shanghai Mental Health Center (SMHC)
Start Date
2025-12-23
Trial ID
NCT07334249
Treatments Being Tested
To evaluate the safety,tolerability and pharmacokinetics of single-multiple...
Status
Completed
Location
Huashan Hospital affiliated to Fudan University
Start Date
2020-07-05
Trial ID
NCT05055687
This study is investigating the safety, tolerability, pharmacodynamics and ...
Status
Completed
Location
Amolyt Pharma Investigational Site Hungary
Start Date
2020-09-07
Trial ID
NCT05239221